These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24723130)

  • 21. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
    Perreault L; Pan Q; Mather KJ; Watson KE; Hamman RF; Kahn SE;
    Lancet; 2012 Jun; 379(9833):2243-51. PubMed ID: 22683134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery.
    Kramer MK; Kriska AM; Venditti EM; Miller RG; Brooks MM; Burke LE; Siminerio LM; Solano FX; Orchard TJ
    Am J Prev Med; 2009 Dec; 37(6):505-11. PubMed ID: 19944916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing diabetes in obese Latino youth with prediabetes: a study protocol for a randomized controlled trial.
    Soltero EG; Konopken YP; Olson ML; Keller CS; Castro FG; Williams AN; Patrick DL; Ayers S; Hu HH; Sandoval M; Pimentel J; Knowler WC; Frick KD; Shaibi GQ
    BMC Public Health; 2017 Mar; 17(1):261. PubMed ID: 28302101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing diabetes with digital health and coaching for translation and scalability (PREDICTS): A type 1 hybrid effectiveness-implementation trial protocol.
    Almeida FA; Michaud TL; Wilson KE; Schwab RJ; Goessl C; Porter GC; Brito FA; Evans G; Dressler EV; Boggs AE; Katula JA; Sweet CC; Estabrooks PA
    Contemp Clin Trials; 2020 Jan; 88():105877. PubMed ID: 31682941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation and evaluation of the VA DPP clinical demonstration: protocol for a multi-site non-randomized hybrid effectiveness-implementation type III trial.
    Damschroder LJ; Moin T; Datta SK; Reardon CM; Steinle N; Weinreb J; Billington CJ; Maciejewski ML; Yancy WS; Hughes M; Makki F; Richardson CR
    Implement Sci; 2015 May; 10():68. PubMed ID: 25962598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a Diabetes Prevention Program Lifestyle Intervention in Older Adults: A Randomized Controlled Study in Three Senior/Community Centers of Varying Socioeconomic Status.
    Kramer MK; Vanderwood KK; Arena VC; Miller RG; Meehan R; Eaglehouse YL; Schafer G; Venditti EM; Kriska AM
    Diabetes Educ; 2018 Apr; 44(2):118-129. PubMed ID: 29514568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early response to preventive strategies in the Diabetes Prevention Program.
    Maruthur NM; Ma Y; Delahanty LM; Nelson JA; Aroda V; White NH; Marrero D; Brancati FL; Clark JM;
    J Gen Intern Med; 2013 Dec; 28(12):1629-36. PubMed ID: 23860722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods.
    Katula JA; Vitolins MZ; Rosenberger EL; Blackwell C; Espeland MA; Lawlor MS; Rejeski WJ; Goff DC
    Contemp Clin Trials; 2010 Jan; 31(1):71-81. PubMed ID: 19758580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of financial incentives on diabetes prevention program attendance and weight loss among low-income patients: the We Can Prevent Diabetes cluster-randomized controlled trial.
    Desai JR; Vazquez-Benitez G; Taylor G; Johnson S; Anderson J; Garrett JE; Gilmer T; Vue-Her H; Rinn S; Engel K; Schiff J; O'Connor PJ
    BMC Public Health; 2020 Oct; 20(1):1587. PubMed ID: 33087083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of a Digital Health Program With Human Coaching for Diabetes Risk Reduction in a Medicare Population.
    Castro Sweet CM; Chiguluri V; Gumpina R; Abbott P; Madero EN; Payne M; Happe L; Matanich R; Renda A; Prewitt T
    J Aging Health; 2018 Jun; 30(5):692-710. PubMed ID: 28553807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost of a group translation of the Diabetes Prevention Program: Healthy Living Partnerships to Prevent Diabetes.
    Lawlor MS; Blackwell CS; Isom SP; Katula JA; Vitolins MZ; Morgan TM; Goff DC
    Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S381-9. PubMed ID: 23498303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Financial incentives for diabetes prevention in a Medicaid population: Study design and baseline characteristics.
    Desai J; Taylor G; Vazquez-Benitez G; Vine S; Anderson J; Garrett JE; Gilmer T; Vue-Her H; Schiff J; Rinn S; Engel K; Michael A; O'Connor PJ
    Contemp Clin Trials; 2017 Feb; 53():1-10. PubMed ID: 27890521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of Diabetes Prevention Program translations among African Americans.
    Samuel-Hodge CD; Johnson CM; Braxton DF; Lackey M
    Obes Rev; 2014 Oct; 15 Suppl 4():107-24. PubMed ID: 25196409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS).
    Fritsche A; Wagner R; Heni M; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Dannecker C; Fritsche L; Valenta V; Schick R; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Dambeck U; Stumvoll M; Blüher M; Birkenfeld AL; Schwarz P; Hauner H; Clavel J; Seißler J; Lechner A; Müssig K; Weber K; Laxy M; Bornstein S; Schürmann A; Roden M; de Angelis MH; Stefan N; Häring HU
    Diabetes; 2021 Dec; 70(12):2785-2795. PubMed ID: 34531293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community-based randomized controlled trial of diabetes prevention study for high-risk individuals of type 2 diabetes: lifestyle intervention using web-based system.
    Cha SA; Lim SY; Kim KR; Lee EY; Kang B; Choi YH; Yoon KH; Ahn YB; Lee JH; Ko SH
    BMC Public Health; 2017 May; 17(1):387. PubMed ID: 28476101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BetaMe: impact of a comprehensive digital health programme on HbA1c and weight at 12 months for people with diabetes and pre-diabetes: study protocol for a randomised controlled trial.
    Sarfati D; McLeod M; Stanley J; Signal V; Stairmand J; Krebs J; Dowell A; Leung W; Davies C; Grainger R
    Trials; 2018 Mar; 19(1):161. PubMed ID: 29506562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors related to lifestyle goal achievement in a diabetes prevention program dissemination study.
    Eaglehouse YL; Venditti EM; Kramer MK; Arena VC; Vanderwood KK; Rockette-Wagner B; Kriska AM
    Transl Behav Med; 2017 Dec; 7(4):873-880. PubMed ID: 28397158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translating the Diabetes Prevention Program Lifestyle Intervention to the Military Setting.
    Kramer MK; Agee SC; Miller RG; Arena VC; Vanderwood KK; Eaglehouse YL; Venditti EM; Kriska AM
    Mil Med; 2023 May; 188(5-6):1036-1045. PubMed ID: 35234887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.